Cargando…

Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure

PURPOSE: The use of sodium-glucose-cotransporter-type-2 inhibitors (SGLT2i) was associated in previous studies with an improved vascular function in non-human experimental models. We therefore sought to evaluate possible changes in endothelial function assessed by flow-mediated dilation (FMD) in pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Correale, Michele, Mazzeo, Pietro, Mallardi, Adriana, Leopizzi, Alessandra, Tricarico, Lucia, Fortunato, Martino, Magnesa, Michele, Tucci, Salvatore, Maiellaro, Pasquale, Pastore, Giuseppe, Lamacchia, Olga, Iacoviello, Massimo, Di Biase, Matteo, Brunetti, Natale Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652233/ https://www.ncbi.nlm.nih.gov/pubmed/34519913 http://dx.doi.org/10.1007/s10557-021-07254-3

Ejemplares similares

Predictors of right ventricular function improvement with sacubitril/valsartan in a real‐life population of patients with chronic heart failure
por: Correale, Michele, et al.
Publicado: (2021)

Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
por: Correale, Michele, et al.
Publicado: (2023)

The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic
por: Correale, Michele, et al.
Publicado: (2021)

SGLT2 Inhibitors: Statins or ACE-Inhibitors of the 21st Century?
por: Correale, Michele, et al.
Publicado: (2023)

Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry
por: Correale, Michele, et al.
Publicado: (2020)

New Targets in Heart Failure Drug Therapy
por: Correale, Michele, et al.
Publicado: (2021)

Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches
por: Correale, Michele, et al.
Publicado: (2021)

Chronic thromboembolic pulmonary hypertension mimicking coronary artery disease
por: Correale, Michele, et al.
Publicado: (2020)

Improvement in Left and Right Ventricular Function after Introduction of SGLT2 Inhibitors in Heart Failure Outpatients with Reduced Ejection Fraction
por: Alcidi, Gianmarco, et al.
Publicado: (2023)

Introduction of SGLT2 Inhibitors and Variations in Other Disease-Modifying Drugs in Heart Failure Patients: A Single-Centre Real-World Experience
por: Tabella, Erika, et al.
Publicado: (2023)

Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach?
por: Brunetti, Natale Daniele, et al.
Publicado: (2020)

Neutrophil/lymphocyte ratio predicts in‐hospital complications in Takotsubo syndrome. Results from a prospective multi‐center registry
por: Santoro, Francesco, et al.
Publicado: (2020)

Prognostic role of neoplastic markers in Takotsubo syndrome
por: Santoro, Francesco, et al.
Publicado: (2021)

Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender
por: Iacoviello, Massimo, et al.
Publicado: (2022)

Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure
por: Alcidi, Gianmarco, et al.
Publicado: (2022)

Biomarkers in Cardiorenal Syndrome
por: Goffredo, Giovanni, et al.
Publicado: (2021)

Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy
por: Santoro, Francesco, et al.
Publicado: (2023)

Hospitalization cost reduction with sacubitril-valsartan implementation in a cohort of patients from the Daunia Heart Failure Registry
por: Correale, Michele, et al.
Publicado: (2019)

Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?
por: Correale, Michele, et al.
Publicado: (2018)

Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization
por: Correale, Michele, et al.
Publicado: (2020)

Chronic thromboembolic pulmonary hypertension
por: Correale, Michele, et al.
Publicado: (2015)

Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis
por: Brunetti, Natale Daniele, et al.
Publicado: (2018)

Coronary thrombosis due to heparin‐induced thrombocytopenia after percutaneous coronary intervention: Easy to miss, uneasy to prevent
por: Mele, Marco, et al.
Publicado: (2020)

The Role of Genetics in the Management of Heart Failure Patients
por: Palmieri, Gianpaolo, et al.
Publicado: (2023)

Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets
por: Correale, Michele, et al.
Publicado: (2023)

The Role of Congestion Biomarkers in Heart Failure with Reduced Ejection Fraction
por: Correale, Michele, et al.
Publicado: (2023)

Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 2—Treatment and Prognosis
por: Santoro, Francesco, et al.
Publicado: (2021)

Arrhythmic myocarditis in an adolescent male: A unique presentation of multi-organ inflammatory syndrome (MIS-C)
por: Casavecchia, Grazia, et al.
Publicado: (2022)

Don’t stop at first glance: pulmonary artery angiosarcoma mimicking chronic thromboembolic pulmonary hypertension
por: Correale, Michele, et al.
Publicado: (2018)

Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy
por: Tarantino, Nicola, et al.
Publicado: (2017)

Effects of Sacubitril/Valsartan on the Renal Resistance Index
por: Gioia, Margherita Ilaria, et al.
Publicado: (2022)

Statin therapy blunts inflammatory activation and improves prognosis and left ventricular performance assessed by Tissue Doppler Imaging in subjects with chronic ischemic heart failure: results from the Daunia Heart Failure Registry
por: Correale, Michele, et al.
Publicado: (2011)

Optimizing Therapies in Heart Failure: The Role of Potassium Binders
por: Scicchitano, Pietro, et al.
Publicado: (2022)

Budget impact analysis of PCSK9 inhibitors costs from a community payers’ perspective in Apulia, Italy
por: Brunetti, Natale Daniele, et al.
Publicado: (2019)

Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?
por: Brunetti, Natale Daniele, et al.
Publicado: (2019)

Does the Measurement of Ejection Fraction Still Make Sense in the HFpEF Framework? What Recent Trials Suggest
por: Palazzuoli, Alberto, et al.
Publicado: (2023)

The PONTE (PDTA FOR INTEGRATED FOLLOW-UP TERRITORY HOSPITAL OF THE PATIENT WITH CARDIAC HEART FAILURE) (BRIDGE) Heart Failure project: increased adherence to guideline-recommended therapies through web-based shared clinical database
por: De Gennaro, Luisa, et al.
Publicado: (2022)

A Case of Pseudo-Hypertrophic Cardiomyopathy: A Congenital Heart Disease
por: Ieva, Riccardo, et al.
Publicado: (2008)

Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register
por: Pastore, Maria Concetta, et al.
Publicado: (2021)

Impact of intra-aortic balloon counterpulsation on all-cause mortality among patients with Takotsubo syndrome complicated by cardiogenic shock: results from the German-Italian-Spanish (GEIST) registry
por: Santoro, Francesco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qq8i35f9lg01ht7h1hr0jncmm8